File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Article: Safe and effective use of digoxin in old age

TitleSafe and effective use of digoxin in old age
Authors
Issue Date1-Jul-2010
PublisherRila Publications
Citation
CME Journal Geriatric Medicine, 2010, v. 12, n. 2, p. 86-97 How to Cite?
Abstract

Digoxin is a common cause of drug-related visits to emergency departments and of hospital admissions. This article promotes the safe prescribing of digoxin by reviewing appropriate indications for its use, manifestations of toxicity, appropriate dosing, therapeutic drug monitoring and clinical monitoring. The Digitalis Intervention Group trial and its post-hoc analyses have helped to redefine a lower and narrower therapeutic digoxin level of 0.6-1.2 nmol/L (0.5-0.9 ng/mL) in the treatment of heart failure. To ensure appropriate dosing clinicians must take into account inter-individual and intra-individual variability in pharmacokinetics and pharmacodyamics, which occur more commonly in older people.


Persistent Identifierhttp://hdl.handle.net/10722/350384
ISSN

 

DC FieldValueLanguage
dc.contributor.authorKong, T-
dc.date.accessioned2024-10-29T00:31:16Z-
dc.date.available2024-10-29T00:31:16Z-
dc.date.issued2010-07-01-
dc.identifier.citationCME Journal Geriatric Medicine, 2010, v. 12, n. 2, p. 86-97-
dc.identifier.issn1475-1453-
dc.identifier.urihttp://hdl.handle.net/10722/350384-
dc.description.abstract<p>Digoxin is a common cause of drug-related visits to emergency departments and of hospital admissions. This article promotes the safe prescribing of digoxin by reviewing appropriate indications for its use, manifestations of toxicity, appropriate dosing, therapeutic drug monitoring and clinical monitoring. The Digitalis Intervention Group trial and its post-hoc analyses have helped to redefine a lower and narrower therapeutic digoxin level of 0.6-1.2 nmol/L (0.5-0.9 ng/mL) in the treatment of heart failure. To ensure appropriate dosing clinicians must take into account inter-individual and intra-individual variability in pharmacokinetics and pharmacodyamics, which occur more commonly in older people.<br></p>-
dc.languageeng-
dc.publisherRila Publications-
dc.relation.ispartofCME Journal Geriatric Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleSafe and effective use of digoxin in old age-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.volume12-
dc.identifier.issue2-
dc.identifier.spage86-
dc.identifier.epage97-
dc.identifier.issnl1475-1453-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats